Summary

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 42.95.

● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● With an enterprise value anticipated at 5.91 times the sales for the current fiscal year, the company turns out to be overvalued.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 130.58 times its estimated earnings per share for the ongoing year.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the past year, analysts have significantly revised downwards their profit estimates.

● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.